Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for the third quarter of fiscal year 2023 (period ended December 31, 2023). With year-to-date strong momentum in its Growth & Launch Products (+12.7% at CER) offsetting the significant revenue impact of generic entrants, Takeda remains on track towards its full-year Management Guidance.
Takeda chief financial officer, Costa Saroukos, commented
“In FY2023 Q3 we made further progress in our vision to discover and deliver life-tr…